Treatment of posttransplant lymphocele with povidone-iodine sclerosis: long-term follow-up.
Percutaneous transcatheter sclerosis with iodate-povidone has been proposed as a treatment of posttransplant lymphocele. We treated 19 lymphoceles with iodate-povidone, 10 of them totally resolved and 6 promptly recurred. Three recurrences were treated conservatively and in 3 the treatment was repeated with success. Therefore, we have a low recurrence and retreatment rate. Our total resolution rate was 100%. Complications due to the treatment were rare. In the long term no patient has developed any renal or perirenal complication related to iodine sclerosis. We conclude that iodine sclerosis is a safe and effective treatment of posttransplant lymphocele. We think that surgical procedures must be reserved to collections adjacent to renal hilum or inaccessible for safe puncturing.
Rivera
M
M
Nephrology Service, Hospital Ramón y Cajal, Madrid, Spain.
Marcén
R
R
Burgos
J
J
Arranz
M
M
Rodriguez
R
R
Teruel
J L
JL
Ortuño
J
J
D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007322:Instillation, Drug; D007466:Iodophors / Q000008:administration & dosage / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology; D008210:Lymphocele / Q000209:etiology / Q000628:therapy*; D011183:Postoperative Complications; D011206:Povidone-Iodine / Q000008:administration & dosage / Q000627:therapeutic use*; D011859:Radiography; D012189:Retrospective Studies; D012598:Sclerosis; D013997:Time Factors; D014517:Ureteral Obstruction / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy
D007166:Immunosuppressive Agents; D007466:Iodophors; D011206:Povidone-Iodine